CX 2020 LIVE programme
Select a session
Session 1 – Tuesday 26 May – Paclitaxel-coated Device Consensus Update
Session 2 – Thursday 28 May – Durability of EVAR, Sac Diameter and NICE Guidelines Consensus
Session 3 – Tuesday 2 June – Superficial Venous Disease Consensus
Session 4 – Thursday 4 June – Aortic Arch Consensus and Stroke from Thoracic Endovascular Procedures (STEP)
Session 5 – Tuesday 9 June – Peripheral Arterial Podium 1st Session
Session 6 – Thursday 11 June – Vascular Access Consensus
Session 7 – Tuesday 16 June – Deep Venous Disease Consensus
Session 8 – Thursday 18 June – Aortic Podium 1st Session
Session 9 – Tuesday 23 June – Acute Stroke Consensus
Session 10 – Thursday 25 June – Juxtarenal Aneurysm Consensus
Session #1 – Tuesday 26 May – 16:00-17:20 BST
Paclitaxel-coated Device Consensus Update
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Andrew Holden, Auckland, New Zealand
16:00-16:05
Podium 1st: Paclitaxel survival results related to DCBs at four years
Sapan Desai, Chicago, United States
16:05-16:10
Audience participation and discussion
16:10-16:15
Paclitaxel dose does not relate to mortality
Sabine Steiner, Leipzig, Germany
16:15-16:20
Audience participation, discussion and polling
16:20-16:25
Follow-up on the paclitaxel-late mortality signal – April 2020 update
Misti Malone, Silver Spring, United States
16:25-16:30
Audience participation, discussion and polling results
Critical limb-threatening ischaemia meta-analyses
16:30-16:35
Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischaemia: A systematic review and meta-analysis of randomised controlled trials
Ramon Varcoe, Randwick, Australia
16:35-16:40
Audience participation and discussion
16:40-16:45
New meta-analysis on DCB for critical limb-threatening ischaemia suggests increased mortality and amputation at one year
Konstantinos Katsanos, Patras, Greece
16:45-16:50
Audience participation and discussion
The value of Individual Patient Data meta-analysis
16:50-16:55
The high-impact of the VIVA IPD meta-analysis
Gary Ansel, Columbus, United States
16:55-17:00
Audience participation, discussion and polling
17:00-17:20
Industry Symposium: Endovascular treatment of complex aorto-iliac occlusive disease
Chairing: Michele Antonello, Padua, Italy
17:00-17:07
Complex occlusive iliac lesions: How to treat them
Amer Zanabili, Oviedo, Spain
17:07-17:14
Case experience
Bella Huasen, Preston, United Kingdom
17:14-17:20
Audience participation and discussion
Session #2 – Thursday 28 May – 16:00-17:20
Durability of EVAR, Sac Diameter and NICE Guidelines Consensus
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Ian Loftus, London, United Kingdom
16:00-16:05
Consensus on the future for EVAR
Michael Jenkins, London, United Kingdom
16:05-16:10
Audience participation, discussion and polling
16:10-16:15
Ultrasound-surveillance after EVAR is feasible
Maarit Venermo, Helsinki, Finland
16:15-16:20
Audience participation and discussion
16:20-16:25
The role of the Society of Vascular Technology of Great Britain and Ireland
Lee Smith, Bolton, President of SVT, United Kingdom
16:25-16:30
Audience participation, discussion and polling results
16:30-16:35
Treatment of type II endoleaks
Lindsay Machan, Vancouver, Canada
16:35-16:40
Audience participation, discussion and polling
16:40-16:45
Contrast-enhanced duplex US for intraoperative assessment of endoleak management
Gustavo Oderich, Rochester, United States
16:45-16:50
Audience participation and discussion
16:50-16:55
Edited case: Expanding indications for aortoiliac disease – key clinical and technical learning from challenging cases
Jorge Fernández Noya, Santiago Compostela, Spain
16:55-17:00
Audience participation, discussion and polling results
17:00-17:20
Industry Symposium: Continuing the pattern of performance
Chairing: Giovanni Pratesi, Genoa, Italy
17:00-17:05
GREAT abdominal endografting questions: What does the data reveal on durability
Jan Heyligers, Tilburg, Netherlands
17:05-17:10
On label treatment of short and angulated neck: Why it matters?: Preliminary learnings from the EXCeL Registry
Giovanni Pratesi, Genoa, Italy
17:10-17:15
On label treatment of short and angulated neck: why it matters? Preliminary learnings from the BSET-CLEVAR
Colin Bicknell, London, United Kingdom
17:15-17:20
Audience participation and discussion
Session #3 – Tuesday 2 June – 16:00-17:00
Superficial Venous Disease Consensus
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Stephen Black, London, United Kingdom
16:00-16:05
European Venous Forum guidelines on varicose veins
Armando Mansilha, Porto, Portugal
16:05-16:10
Audience participation and discussion
16:10-16:15 2020
European Society of Vascular Surgery Venous Thrombosis guidelines – implications for superficial vein thrombosis
Manj Gohel, Cambridge, United Kingdom
16:15-16:20
Audience participation and discussion
16:20-16:25
Classification and treatment of endothermal heat induced thrombosis: Recommendations from the American Venous Forum
Lowell Kabnick, New York, United States
16:25-16:30
Audience participation and discussion
16:30-16:35
Clinical assessment and work-up of patients with possible pelvic congestion syndrome
Alexsandra Jaworucka-Kaczorowska, Gorzów Wielkopolski, Poland
16:35-16:40
Audience participation and discussion
16:40-16:45
Podium 1st: Network meta-analysis comparing cyanoacrylate glue with other superficial venous therapies for chronic venous insufficiency
Raghu Kolluri, Columbus, President of ASVM, United States
16:45-16:50
Audience participation, discussion and polling
16:50-16:55
Edited case: Step by step procedure using a cyanoacrylate glue closure system
Kathleen Gibson, Bellevue, United States
16:55-17:00
Audience participation, discussion and polling results
Session #4 – Thursday 4 June – 16:00-17:20
Aortic Arch Consensus and Stroke from Thoracic Endovascular Procedures (STEP)
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Stephan Haulon, Paris, France
16:00-16:05
Endovascular treatment for aortic arch pathologies: Chimney on-the-table fenestration and in-situ fenestration technique
Ludovic Canaud, Montpellier, France
16:05-16:10
Audience participation, discussion and polling
16:10-16:15
Options for left subclavian branch
Gustavo Oderich, Rochester, United States
16:15-16:20
Audience participation and discussion
16:20-16:25
Feasibility of endovascular arch repair post type A dissection
Kevin Mani, Uppsala, Sweden
16:25-16:30
Audience participation, discussion and polling results
16:30-16:35
Aortic arch aneurysms: Total endovascular, hybrid, open and frozen elephant trunk – which is the best and when
Roberto Chiesa, Milan, Italy
16:35-16:40
Audience participation, discussion and polling
16:40-16:45
The value of DW MRI imaging to reduce stroke – Paris and Hamburg combined arch reconstruction experience
Philippe Charbonneau, Paris/Hamburg
16:45-16:50
Audience participation and discussion
16:50-16:55
Edited case: Carotid to subclavian bypass and vascular plug subclavian endovascular occlusion before thoracic open or endovascular repair
Luca Bertoglio, Milan, Italy
16:55-17:00
Audience participation, discussion and polling results
17:00-17:20
Industry Symposium: Advancing Thoracic Care
Chairing: Ali Azizzadeh, Los Angeles, United States
17:00-17:05
When is the use of angulation control beneficial in TEVAR
Hence Verhagen, Oegstgeest, Netherlands
17:05-17:10
TEVAR in acute uncomplicated type B dissection – where are we today?
Richard Gibbs, London, United Kingdom
17:10-17:15
Is distal oversizing the sole reason for distal SINE in chronic dissection and are there device specific differences?
Santi Trimarchi, Milan, Italy
17:15-17:20
Audience participation and discussion
Session #5 – Tuesday 9 June – 16:00-17:20
Peripheral Arterial Podium 1st Session
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Gunnar Tepe, Rosenheim, Germany
16-00-16:05
A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease
Jean-Paul de Vries, Groningen, Netherlands
16:05-16:10
Audience participation and discussion
16:10-16:15
Value of a new balloon-expandable stent graft in treating challenging aortoiliac occlusive lesions – three-year results, advantages and limitations
Andrew Holden, Auckland, New Zealand
16:15-16:20
Audience participation and discussion
16:20-16:25
Edited case: Relining of occlusive long TASC D iliac lesion
Amer Zanabili, Oviedo, Spain
16:25-16:30
Audience participation, discussion and polling
16:30-16:35
VOYAGER: The role of rivaroxaban in PAD lower extremity revascularisation patients
Rupert Bauersachs, Darmstadt, Germany
16:35-16:40
Audience participation, discussion and polling
16:40-16:45
MIMICS-2 study three-year results
Thomas Zeller, Bad Krozingen, Germany
16:45-16:50
Audience participation and discussion
16:50-16:55
Absence of long-term benefit of revascularisation in claudicants – five-year results from the IRONIC randomised trial
Joakim Nordanstig, Molndal, Sweden
16:55-17:00
Audience participation, discussion and polling results
17:00-17:20
Industry Symposium: Overcoming the limitations of paclitaxel: A new sirolimus-coated balloon for the treatment of PVD
Chairman: Francesco Liistro, Arezzo, Italy
17:00-17:05
Prospect and appraisal of a new sirolimus-coated balloon over paclitaxel for the treatment of PAD
Aloke Finn, Gaithersburg, United States
17:05-17:11
Six-month XTOSI results and rationale for randomised trials of SCB versus POBA
Edward Choke, Singapore
17:11-17:16
Outcomes of sirolimus-coated balloon in the treatment of dysfunctional AVF and AVG
Tan Chieh Suai, Singapore
17:16-17:17
DEBATE BTK DueIL Trials
Francesco Liistro, Arezzo, Italy
17:17-17:20
Audience participation and discussion
Session #6 – Thursday 11 June – 16:00-17:00
Vascular Access Consensus
Chairman: Nicholas Inston, Birmingham, United Kingdom
Moderator: Domenico Valenti, London, United Kingdom
16:00-16:05
Pre-operative assessment and planning
Jennifer Hanko, Belfast, United Kingdom
16:05-16:10
Audience participation and discussion
16:10-16:15
External support device to improve fistula outcomes
Robert Shahverdyan, Hamburg, Germany
16:15-16:20
Audience participation, discussion and polling
16:20-16:25
EndoAVF technology update
Robert Jones, Birmingham, United Kingdom
16:25-16:30
Audience participation and discussion
16:30-16:35
Edited case: Endovascular creation of an arteriovenous fistula
Panagiotis Kitrou, Patras, Greece
16:35-16:40
Audience participation, discussion and polling
16:40-16:45
A new era of AV access creation and maintenance: Increasing circuit longevity with a new treatment pathway
David Kingsmore, Glasgow, United Kingdom
16:45-16:50
Audience participation and discussion
16:50-16:55
Edited case: Self-expanding covered endoprosthesis to treat failure of arteriovenous fistulas at the venous anastomosis
Matteo Tozzi, Varese, Italy
16:55-17:00
Audience participation, discussion and polling results
Session #7 – Tuesday 16 June – 16:00-17:20
Deep Venous Disease Consensus
Chairman: Armando Mansilha, Porto, Portugal
Moderator: Manj Gohel, Cambridge, United Kingdom
16:00-16:05
Designing venous stents to cope with venous anatomy: What is needed below the ligament
Christopher Cheng, Stanford, California, United States
16:05-16:10
Audience participation and discussion
16:10-16:15
Medical therapy after deep venous interventions
Michael Jolly, Powell, United States
16:15-16:20
Audience participation and discussion
16:20-16:25
New validated anatomic classification of chronic venous obstruction of the iliofemoral tract and its clinical implications
Houman Jalaie, Aachen, Germany
16:25-16:30
Audience participation and discussion
16:30-16:35
The essential components for delivering a deep venous service
Gerard O’Sullivan, Galway, Ireland
16:35-16:40
Audience participation and discussion
16:40-16:45
Podium 1st: Twelve-month results from the ABRE study
Stephen Black, London, United Kingdom
16:45-16:50
Audience participation, discussion and polling
16:50-16:55
Optimising patient selection in the treatment of non-thrombotic iliac vein lesions
Brian DeRubertis, Los Angeles, United States
16:55-17:00
Audience participation, discussion and polling results
17:00-17:20
Industry Symposium: VERNACULAR Trial update
Chairman: Houman Jalaie, Aachen, Germany
17:00-17:10
Highlights of the VERNACULAR Trial and real-world experience with a venous stent
Gerard O’Sullivan, Galway, Ireland
17:10-17:20
Audience participation and discussion
Session #8 – Thursday 18 June – 16:00-17:20
Aortic Podium 1st Session
Chairman: Gustavo Oderich, Rochester, United States
Moderator: Roberto Chiesa, Milan, Italy
Abdominal Aortic
16:00-16:05
Expanding clinical experience using fibre optic technology in complex aortic repair
Tilo Kölbel, Hamburg, Germany
16:05-16:10
Audience participation and discussion and polling
16:10-16:15
ESAR in a challenging seal zone can be an effective treatment: Early mid-term results
Frank Arko, Charlotte, United States
16:15-16:20
Audience participation and discussion
16:20-16:25
Best practice with a low profile AAA stent graft in 139 patients
Eric Verhoeven, Nuremberg, Germany
16:25-16:30
Audience participation, discussion and polling results
Thoracic Aortic
16:30-16:35
Wrapping of the ascending aorta as an option for acute type A dissections
Stephan Haulon, Paris, France
16:35-16:40
Audience participation and discussion
16:40-16:45
First results from the European SURPASS registry
Giovanni Torsello, Münster, Germany
16:45-16:50
Audience participation and discussion
16:50-16:55
Tailor fragile aorta treatment with latest generation thoracic stent graft system
Fabio Verzini, Turin, Italy
16:55-17:00
Audience participation and discussion
17:00-17:20
Industry Symposium: Intravascular Lithotripsy (IVL) for EVAR access and AIOD
Chairman: Roger Greenhalgh, London, United Kingdom
Moderator: Andrew Holden, Auckland, New Zealand
17:00-17:05
Introduction and challenges of aortoiliac calcium
Frank Arko, Charlotte, United States
17:05-17:10
IVL for calcified EVAR access
Arne Schwindt, Münster, Germany
17:10-17:15
IVL in calcified AIOD
Andrew Holden, Auckland, New Zealand
17:15-17:20
Audience participation and discussion
Session #9 – Tuesday 23 June – 16:00-17:00
Acute Stroke Consensus
Chairman: Hugh Markus, Cambridge, United Kingdom
Moderator: Ross Naylor, Leicester, United Kingdom
16:00-16:05
When operating on a carotid artery in a patient undergoing CABG the two should be done simultaneously
Barbara Rantner, Munich, Germany
16:05-16:10
Audience participation, discussion and polling
16:10-16:15
International variation in carotid surgery is huge despite all the randomised trials performed
Maarit Venermo, Helsinki, Finland
16:15-16:20
Audience participation and discussion
16:20-16:25
Risk of cardiovascular events and death in patients with asymptomatic bilateral carotid artery stenosis: A population-based cohort study
Dominic Howard, Oxford, United Kingdom
16:25-16:30
Audience participation, discussion and polling results
16:30-16:35
Outcomes of carotid artery stenting in selected patients are now as good or better than endarterectomy
Peter Schneider, Honolulu, United States
16:35-16:40
Audience participation and discussion
16:40-16:45
Intracranial stenting for stenosis is not dead
Andrew Clifton, London, United Kingdom
16:45-16:50
Audience participation and discussion
16:50-16:55
Validation studies of virtual reality simulation performance metrics for mechanical thrombectomy in ischaemic stroke
Lars Lönn, Copenhagen, Denmark
16:55-17:00
Audience participation and discussion
Session #10 – Thursday 25 June – 16:00-17:00
Juxtarenal Aneurysm Consensus
Chairman: Stephan Haulon, Paris, France
Moderator: Gustavo Oderich, Rochester, United States
16:00-16:05
The advantage of inner branch technology in resolving the current challenges in fenestrated and branched solutions – large centre experience and lessons learnt
Said Abisi, London, United Kingdom
16:05-16:10
Audience participation and discussion
16:10-16:15
Edited case: Repair of a thoracoabdominal aortic aneurysm using an off the shelf endovascular graft
Bijan Modarai, London, United Kingdom
16:15-16:20
Audience participation and discussion
16:20-16:25
Technical success and endoleaks for surgeon-modified fenestrated endografts vs. custom-made fenestrated endografts
Nikolaos Tsilimparis, Munich, Germany
16:25-16:30
Audience participation and discussion
16:30-16:35
Single-centre experience with the new bridging stent grafts in FEVAR and BEVAR grafting
Eric Verhoeven, Nuremberg, Germany
16:35-16:40
Audience participation and discussion
16:40-16:45
Advantages of balloon-expandable covered bridging stents in FEVAR and BEVAR procedures: Which one is best and why
Mauro Gargiulo, Bologna, Italy
16:45-16:50
Audience participation, discussion and polling
16:50-16:55
Off-the-shelf solutions for hostile necks: how to achieve durability while minimizing hospital resource impact
Jean-Paul de Vries, Groningen, Netherlands
16:55-17:00
Audience participation, discussion and polling results